AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 169 filers reported holding AXSOME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $35,930 | +16.5% | 500 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $30,840 | -20.0% | 500 | 0.0% | 0.01% | -25.0% |
| Q4 2022 | $38,565 | +75.3% | 500 | 0.0% | 0.01% | +60.0% |
| Q3 2022 | $22,000 | +15.8% | 500 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $19,000 | -9.5% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $21,000 | +10.5% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $19,000 | +18.8% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $16,000 | -52.9% | 500 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $34,000 | +21.4% | 500 | 0.0% | 0.01% | +14.3% |
| Q1 2021 | $28,000 | -31.7% | 500 | 0.0% | 0.01% | -41.7% |
| Q4 2020 | $41,000 | +13.9% | 500 | 0.0% | 0.01% | +9.1% |
| Q3 2020 | $36,000 | -12.2% | 500 | 0.0% | 0.01% | -26.7% |
| Q2 2020 | $41,000 | -21.2% | 500 | 0.0% | 0.02% | -16.7% |
| Q1 2020 | $52,000 | 0.0% | 500 | 0.0% | 0.02% | 0.0% |
| Q4 2019 | $52,000 | +420.0% | 500 | 0.0% | 0.02% | +350.0% |
| Q3 2019 | $10,000 | -23.1% | 500 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $13,000 | – | 500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |